Akiko Furue

No ORCID on file · 6 papers in corpus · active 2020-2025

Study types

  • article 6

Condition tags

  • endometriosis 6
  • mesh:D004715 3
article 2025
In vivo (Athens, Greece) ·doi:10.21873/invivo.14059

Background/Aim: Endometriosis is characterized by the accumulation of immune cells in endometrial lesions and the peritoneal cavity. Macrophages contribute to the growth and neovascularization of endometriotic lesions. Vascular endothelial …

article 2023
Molecular medicine reports ·doi:10.3892/mmr.2023.13079

Endometriosis is highly dependent on angiogenesis and lymphangiogenesis. Prostaglandin E2, an arachidonic acid metabolite, has been shown to promote the formation of new blood and lymphatic vessels. However, the role of another arachidonic …

article 2022
·doi:10.1254/jpssuppl.96.0_2-b-p-091

Angiogenesis and lymphangiogenesis contribute to the development of endometriosis. We recently reported that thromboxane A2 (TXA2) receptor signaling involves in angiogenesis in critical limb ischemia and lymphangiogenesis in inflamed diaph…

article 2021
Scientific reports ·doi:10.1038/s41598-020-79578-3

In endometriosis, M2 MΦs are dominant in endometriotic lesions, but the actual role of M2 MΦ is unclear. CD206 positive (+) MΦ is classified in one of M2 type MΦs and are known to produce cytokines and chemokines. In the present study, we u…

article 2021
Biomedicines ·doi:10.3390/biomedicines9111519

Sphingosine 1-phosphate (S1P), an inflammatory mediator, is abundantly contained in red blood cells and platelets. We hypothesized that the S1P concentration in the peritoneal cavity would increase especially during the menstrual phase due …

article 2020
·doi:10.1016/j.jri.2020.103238